clive landis

Clive Landis | Agility and alignment: UWI research and innovation deployed in response to COVID-19

In answering the question on vaccine development posed by the editorial, it is important to understand that today’s recombinant vaccine technology requires constant investment by the State to build capacity in molecular technology, genetics and artificial intelligence, as well as private sector investment to build out the pharmaceutical and biotechnology sectors. The countries leading the race to generate a vaccine…